A randomized clinical trial of excision versus photodynamic therapy in the treatment of Bowen's disease

A randomized clinical trial of excision versus photodynamic therapy in the treatment of Bowen's disease - Morbus Bowen: excision versus photodynamic therapie

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON30319

Enrollment

224

Registered

2007-01-04

Start date

2007-05-25

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraepithelial squamous cell carcinoma skincancer

Interventions

Excision or PDT

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Histopathologic proven Bowen's disease scalp, face, torso, arms and legs Age > 18 years Informed consent

Exclusion criteria

Exclusion criteria: Recurrent Bowen's disease Anogenital or subungual Bowen's disease Other skin malagnancies in the same area Porfyria

Design outcomes

Primary

Measure	Time frame
Recurrence rate	—

Secondary

Measure	Time frame
Cosmetic outcome Cost-utility	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)